Astria Therapeutics (ATXS) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free ATXS Stock Alerts $9.00 -0.64 (-6.64%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Astria Therapeutics (NASDAQ:ATXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$41.58 MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$111,396.00 Get ATXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Astria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATXS Insider Buying and Selling by Quarter Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Astria Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/1/2024Perceptive Advisors LlcDirectorBuy2,481,350$12.09$29,999,521.50 1/29/2024Christopher MorabitoinsiderSell9,200$11.15$102,580.00 1/26/2024Christopher MorabitoinsiderSell800$11.02$8,816.00 12/21/2023Perceptive Advisors LlcDirectorBuy740,000$6.20$4,588,000.00 10/16/2023Perceptive Advisors LlcDirectorBuy1,074,608$6.51$6,995,698.08 (Data available from 1/1/2013 forward) ATXS Insider Trading Activity - Frequently Asked Questions Who is on Astria Therapeutics's Insider Roster? The list of insiders at Astria Therapeutics includes Andrew Komjathy, Christopher Morabito, and Perceptive Advisors Llc. Learn more on insiders at ATXS. What percentage of Astria Therapeutics stock is owned by insiders? 3.40% of Astria Therapeutics stock is owned by insiders. Learn more on ATXS's insider holdings. Which Astria Therapeutics insiders have been buying company stock? The following insider purchased ATXS shares in the last 24 months: Perceptive Advisors Llc ($51,583,217.23). How much insider buying is happening at Astria Therapeutics? Insiders have purchased a total of 5,204,223 ATXS shares in the last 24 months for a total of $51,583,217.23 bought. Which Astria Therapeutics insiders have been selling company stock? The following insider sold ATXS shares in the last 24 months: Christopher Morabito ($111,396.00). How much insider selling is happening at Astria Therapeutics? Insiders have sold a total of 10,000 Astria Therapeutics shares in the last 24 months for a total of $111,396.00 sold. More Insider Trading Tools from MarketBeat Related Companies: Nuvation Bio Insider Buying Lyell Immunopharma Insider Buying Olema Pharmaceuticals Insider Buying Mineralys Therapeutics Insider Buying Verve Therapeutics Insider Buying Zymeworks Insider Buying Korro Bio Insider Buying Phathom Pharmaceuticals Insider Buying SIGA Technologies Insider Buying ORIC Pharmaceuticals Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ATXS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
